Amundi’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $174M | Sell |
|
|||||
|
2025
Q2 | $130M | Sell |
|
|||||
|
2025
Q1 | $119M | Sell |
|
|||||
|
2024
Q4 | $119M | Sell |
|
|||||
|
2024
Q3 | $161M | Sell |
|
|||||
|
2024
Q2 | $183M | Sell |
|
|||||
|
2024
Q1 | $108M | Buy |
|
|||||
|
2023
Q4 | $141M | Buy |
|
|||||
|
2023
Q3 | $103M | Sell |
|
|||||
|
2023
Q2 | $128M | Buy |
|
|||||
|
2023
Q1 | $131M | Sell |
|
|||||
|
2022
Q4 | $150M | Sell |
|
|||||
|
2022
Q3 | $240M | Buy |
|
|||||
|
2022
Q2 | $126M | Buy |
|
|||||
|
2022
Q1 | $142M | Buy |
|
|||||
|
2021
Q4 | $37.6M | Sell |
|
|||||
|
2021
Q3 | $49.2M | Buy |
|
|||||
|
2021
Q2 | $36.3M | Buy |
|